Drug Shortage Report for TOUJEO SOLOSTAR
Report ID | 175125 |
Drug Identification Number | 02441829 |
Brand name | TOUJEO SOLOSTAR |
Common or Proper name | TOUJEO SOLOSTAR |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN GLARGINE |
Strength(s) | 300UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 5 |
ATC code | A10AE |
ATC description | INSULINS AND ANALOGUES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-11-11 |
Estimated end date | 2022-11-25 |
Actual end date | 2022-11-21 |
Shortage status | Resolved |
Updated date | 2022-11-23 |
Company comments | Requirements related to complying with good manufacturing practices. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-11-23 | French | Compare |
v3 | 2022-11-23 | English | Compare |
v2 | 2022-11-17 | French | Compare |
v1 | 2022-11-17 | English | Compare |
Showing 1 to 4 of 4